Adderall and Doxylamine succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) and Doxylamine succinate (doxylamine succinate). Common drug interactions include sinusitis among females and neuralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Adderall and Doxylamine succinate. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Adderall?

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,226 Adderall users. Check the latest studies of Adderall.

What is Doxylamine succinate?

Doxylamine succinate has active ingredients of doxylamine succinate. It is often used in insomnia. eHealthMe is studying from 2,851 Doxylamine succinate users. Check the latest studies of Doxylamine succinate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

19 people who take Adderall and Doxylamine succinate together, and have interactions are studied.

Adderall and Doxylamine succinate drug interactions.

What are the common drug interactions of Adderall and Doxylamine Succinate, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Oral herpes (viral infection of mouth)
  3. Fatigue (feeling of tiredness)
  4. Fungal infection
  5. Headache (pain in head)
  6. Mastitis (inflammation of breast)
  7. Uterine infection
  8. Anxiety
  9. Pruritus (severe itching of the skin)
  10. Vulvovaginal mycotic infection (vulvovaginal fungal infection)

male:

  1. Neuralgia (pain in one or more nerves)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Empyema (collection of pus in a cavity in the body)
  4. Pericardial effusion (fluid around the heart)
  5. Postoperative wound infection
  6. Diarrhoea
  7. Drug ineffective
  8. Injury
  9. Retinal tear
  10. Seborrhoeic keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest)

What are the common drug interactions of Adderall and Doxylamine Succinate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Laryngitis (inflammation of the larynx)
  2. Upper respiratory tract infection
  3. Infusion site extravasation (flow of (blood or lymph) from infusion site)

30-39:

  1. Uterine infection
  2. Pruritus (severe itching of the skin)
  3. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  4. Cough
  5. Erythema (redness of the skin)
  6. Fatigue (feeling of tiredness)
  7. Influenza
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Paranasal sinus discomfort
  10. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

40-49:

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness)
  2. Sleep attacks

50-59:

  1. Diarrhoea
  2. Drug ineffective
  3. Therapeutic response unexpected

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 42.11%
  2. Immunodeficiency Common Variable: 8 people, 42.11%
  3. Neuralgia (pain in one or more nerves): 4 people, 21.05%
  4. Stress And Anxiety: 2 people, 10.53%
  5. Immunodeficiency: 2 people, 10.53%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 10.53%
  7. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Adderall and Doxylamine succinate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adderall and Doxylamine succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adderall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Doxylamine succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adderall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxylamine succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate and doxylamine succinate (the active ingredients of Adderall and Doxylamine succinate, respectively), and Adderall and Doxylamine succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: